Baylor College of Medicine

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

Retrieved on: 
Monday, April 8, 2024
Public health, Growth, Hematology, Patient, SVP, BMS, Science, Cancer, CRISPR Therapeutics, Baylor College of Medicine, Pleasure, Merrimack Pharmaceuticals, Therapy, Drug development, TCR, Tropical medicine, Pharmaceutical industry

Dr. Louis has extensive experience in hematology and oncology drug development, with a track record of success in clinical development, medical affairs, and commercialization.

Key Points: 
  • Dr. Louis has extensive experience in hematology and oncology drug development, with a track record of success in clinical development, medical affairs, and commercialization.
  • “We are excited to welcome Chrystal to TScan at this critical time as we continue to progress both clinical-stage programs in heme malignancies and solid tumors.
  • “I look forward to working with Chrystal as we strive to realize the full potential of our pipeline.
  • Prior to joining TScan, Dr. Louis was the SVP of hematology clinical development at Zentalis Pharmaceuticals.

Brain & Behavior Research Foundation Awards Distinguished Investigator Grants Valued at $1 Million to 10 Scientists Pursuing Innovative Mental Health Research

Retrieved on: 
Thursday, April 4, 2024
Depression, Patient, Mitochondrion, Doctor of Science, Harvard University, Therapy, Research, Risk, Mental health, University of Pittsburgh, Brain, DSM-IV codes, Brown University, Cannabis, Memory, Safety, Spectrum, Mitophagy, Schizophrenia, Hippocampus, Bipolar disorder, Anxiety, Learning, University, Psychopathology, Cerebrospinal fluid, University of California, Distinguishing, PET, Biomarker, Hope, Baylor College of Medicine, Behavior, AMPA, Fragile X syndrome, PTSD, Pharmaceutical industry

New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.

Key Points: 
  • New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.
  • By funding transformative research focused on new ways to prevent, diagnose, and treat psychiatric disorders, our Distinguished Investigator Grants are encouraging established scientists to continue advancing our understanding of mental illness and disorders of brain and behavior,” says Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation.
  • The ground-breaking work of the Distinguished Investigator Grant recipients will bring hope and healing to people and families impacted by mental illness.
  • We applaud these scientists for their extraordinary dedication, innovation, and leadership.”
    Recipients of the Distinguished Investigator Grants are full professors at research institutions in the United States and abroad.

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, March 28, 2024
Transcoding, Internal medicine, Temple University Hospital, CFO, Oncology, Patient, RNA, University, Cancer, University of Pittsburgh, Yale School of Medicine, Baylor College of Medicine, Infection, Therapy, Harvard University, Interim, Muscular dystrophy, Yale University, Pharmacia, Pharmaceutical industry

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.

Key Points: 
  • BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.
  • Dr. Vlock is a medical oncologist with over 25 years of industry experience and 15 years in academia, including renowned institutions Yale University, University of Pittsburgh, and Harvard University.
  • While at Pharmacia, Dr. Vlock ran the Celebrex Oncology program involving two pivotal clinical trials and over 3,500 patients.
  • Dr. Vlock initially will serve on a part-time basis through TransCode’s arrangement with BioBridges LLC, a life sciences consulting company.

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Retrieved on: 
Tuesday, March 12, 2024
Principal, GP2, Faculty, Breast cancer, Gregorio, Immunotherapy, Disease, Patient, Knowledge, GM-CSF, Research, Hospital, Observation, Pi, Cancer, Death, Teaching hospital, Baylor College of Medicine, ECIS, Complutense University of Madrid, Woman, Prognosis, Book, Vaccine, Map

The Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 hospitals have agreed to participate in FLAMINGO-01.

Key Points: 
  • The Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 hospitals have agreed to participate in FLAMINGO-01.
  • These sites were recently approved by Spanish authorities, which led to site initiation visits and training of the first sites this past week.
  • Founded in 1995, GEICAM is a not-for-profit organization leading academic breast cancer research in Spain.
  • Breast cancer is the leading cause of death in women between the ages 35-45 in Spain with 6,836 deaths in 2022.

Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink of extinction

Retrieved on: 
Thursday, March 28, 2024
Research, Environmental Issues, Other Natural Resources, Technology, Natural Resources, Environment, Genetics, Science, Veterinary, Other Technology, Other Science, Health, Elephant, Leibniz Association, NGO, Partnership, Risk, Female, Human, Fungus, De-extinction, AI, Life, Baylor College of Medicine, Biodiversity, Exploration, IUCN, Colossal Biosciences, Indigenous peoples, Vietnamese people, CRISPR, Ecosystem, Thylacine, Zoo, Baylor University, Hunting

A vaccine could help increase the population of Asian elephants because more calves would survive to adulthood and eventually breed.

Key Points: 
  • A vaccine could help increase the population of Asian elephants because more calves would survive to adulthood and eventually breed.
  • Colossal and Re:wild, working with local and international partners and governments, will then be able to restore a genetically robust population of this species.
  • (AI image courtesy of Colossal Biosciences; Tasmanian devil photo by Aussie Ark)
    Re:wild protects and restores the wild.
  • Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth.

Rockwell Automation Names Stephen Ford Chief Information Security Officer

Retrieved on: 
Tuesday, March 12, 2024
Other Manufacturing, Electronic Design Automation, Machinery, Machine Tools, Metalworking & Metallurgy, Engineering, Technology, Manufacturing, Other Technology, Automation, Black, University, McKesson Corporation, Baylor College of Medicine, MBA, Rockwell Automation, Harvard University, University of Texas System, GlobalSecurity.org, HP, Management

Rockwell Automation (NYSE:ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that Stephen Ford is joining the company as vice president and Chief Information Security Officer, effective immediately.

Key Points: 
  • Rockwell Automation (NYSE:ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that Stephen Ford is joining the company as vice president and Chief Information Security Officer, effective immediately.
  • He will report to Chris Nardecchia, senior vice president and Chief Information Officer at Rockwell Automation.
  • In this role, Stephen will develop and execute a holistic cybersecurity strategy to ensure that Rockwell and our Connected Enterprise ecosystem—the company’s infrastructure, products, and customers—are safe, secure, and resilient.
  • In this role, he led teams overseeing cybersecurity operations, offensive security, incident response, security engineering architecture, and access management.

Experts to examine how Supreme Court Affirmative Action decision impacts legal and medical education at upcoming University of Houston event

Retrieved on: 
Wednesday, April 3, 2024
Constitution, Internal medicine, Tilman, Professional development, SFFA, University, Harvard University, Nature, Associate professor, DEI, Inclusion, Equal Protection Clause, Dean (education), University college, Family medicine, Virginia School for Girls, Diversity, Environmental studies, Law School Admission Council, Supreme court, Operation, MPP, University of Houston, MCLE, College of Medicine, Associate, Community health, Student, Community engagement, Supreme, Law Center, Medical school, McGovern Medical School, Psychiatry, Assistant, Behavioural sciences, LSAC, Baylor College of Medicine, CME, Management

"In SFFA v. Harvard, the U.S. Supreme Court found that the race-conscious admission policies of Harvard University and the University of North Carolina violated the Equal Protection Clause of the U.S. Constitution," said UH Law Center Dean Leonard Baynes.

Key Points: 
  • "In SFFA v. Harvard, the U.S. Supreme Court found that the race-conscious admission policies of Harvard University and the University of North Carolina violated the Equal Protection Clause of the U.S. Constitution," said UH Law Center Dean Leonard Baynes.
  • "The Supreme Court decisions on affirmative action have reshaped the landscape at medical schools across the country," said Dr. Stephen Spann, founding dean of the Fertitta Family College of Medicine.
  • "It is important to understand the impacts, so our students continue receiving the best health care education and our clinicians continue providing quality health care services to the community."
  • Attending healthcare and legal professionals will earn 6 hours of Texas MCLE credit or 6.25 CME credits, respectively.

Rockwell Automation Names Stephen Ford Chief Information Security Officer

Retrieved on: 
Thursday, March 21, 2024
Automation, Black, University, McKesson Corporation, Baylor College of Medicine, MBA, African, Rockwell Automation, Harvard University, University of Texas System, GlobalSecurity.org, HP, Management

BRUSSELS, March 21, 2024 /PRNewswire/ -- Rockwell Automation, the world's largest company dedicated to industrial automation and digital transformation, today announced that Stephen Ford is joining the company as vice president and Chief Information Security Officer, effective immediately.

Key Points: 
  • BRUSSELS, March 21, 2024 /PRNewswire/ -- Rockwell Automation, the world's largest company dedicated to industrial automation and digital transformation, today announced that Stephen Ford is joining the company as vice president and Chief Information Security Officer, effective immediately.
  • He will report to Chris Nardecchia, senior vice president and Chief Information Officer at Rockwell Automation.
  • Stephen joins Rockwell from McKesson Corporation, a leader in pharmaceutical and medical supplies distribution, where he was Vice President, Global Security.
  • In this role, he led teams overseeing cybersecurity operations, offensive security, incident response, security engineering architecture, and access management.

Allelica to provide multi-ancestry polygenic risk score to Baylor College of Medicine for clinical implementation

Retrieved on: 
Tuesday, March 19, 2024
WGS, Health informatics, Informatics, Coronary artery disease, Associate, Patient, PRS, ASHG, Human genetics, Laboratory, Whole genome sequencing, Baylor College of Medicine, Society, Traction, BCM, Physician, Health

NEW YORK, March 19, 2024 /PRNewswire/ -- Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio.

Key Points: 
  • NEW YORK, March 19, 2024 /PRNewswire/ -- Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio.
  • This marks a significant milestone in making world class genomic medicine accessible, equitable, and impactful for patients across diverse communities.
  • Allelica's PRS solution enables more precise identification of patients' genetic risk for coronary artery disease and other diseases and traits.
  • Baylor is one of several institutions working with Allelica to provide clinical PRS testing to patients.

Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions

Retrieved on: 
Monday, March 4, 2024
Surgeon, PEMF, Pain, Department of Defence, Chronic pain, Electromagnetic field, Organization, SDVOSB, OTC, Army, Edema, Length of stay, Veteran, Service-Disabled Veteran-Owned Small Business, Baylor University, Distribution, Opioid, Traumatic brain injury, Use, FSS, Conference, Safety, Morphine, Acquisition, Inflammation, FDA, Visual analogue scale, DAPA, Baylor College of Medicine, Nursing

Los Angeles, CA, March 04, 2024 (GLOBE NEWSWIRE) -- SofPulse Inc. -- a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed spin-off company -- announced today the participation of its SofPulse® Pulsed Electro-Magnetic Field (PEMF) FDA-cleared medical device in the United States Army Medical Research and Development Command (USAMRDC) May 2024 Vendor Day.

Key Points: 
  • The command unit has a key role in identifying innovative pain management solutions for Veterans Administration (VA) and Department of Defense (DoD) patients and uses.
  • SofPulse®, along with its VA reseller, Academy Medical Inc., is planning to showcase SofPulse® and its non-evasive, drug-free pain management solution to the VA and military attendees.
  • SofPulse® featured by Academy Medical at USAMRDC Vendor Day, offers extended exposure for the opportunity to present and demonstrate its innovative pain management solutions to multiple organizations at one time.
  • Integrating SofPulse® into its post-operative pain management protocols, the VA can improve the quality of care and enhance the well-being of veterans nationwide.